Both in Pharmaceuticals
Amneal Pharmaceuticals vs Axsome Therapeutics
Over the past year AMRX returned +75.8% and AXSM returned +1.5%; their daily moves had a correlation of 0.24.
AMRX +75.8% AXSM +1.5%Growth of $1, one year, split-adjusted
| Metric | AMRX | AXSM |
|---|---|---|
| Price | $19.95 | $137.00 |
| Market cap | $6.95B | $7.18B |
| Today | −1.29% | −1.87% |
| 1 month | −1.7% | −21.4% |
| 6 months | +46.5% | −38.5% |
| Year to date | +58.3% | −25.0% |
| 1 year | +78.2% | +0.9% |
| Revenue growth (YoY) | +9.9% | +51.9% |
| Gross margin | 42.0% | 93.1% |
| Net margin | 7.2% | −5.0% |
| P/E (TTM) | 44.2× | — |
| Price / sales | 2.2× | 8.3× |
| Net cash | -$2.54B | $116.6M |
| Dividend yield | — | — |
| Volatility (60d) | 38.0% | 38.0% |
| Short % of float | 8.2% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).